Planned British DNA database could boost drug R&D

12/10/2012 | Financial Times (tiered subscription model) · Reuters

The British government has allotted $160 million to create a genome database of as many as 100,000 patients with cancer and rare conditions over the next three to five years. The project could change the way complex illnesses are diagnosed and treated as well as enhance the discovery and development of novel drugs, and it allow researchers to work with data from the National Health Service, Prime Minister David Cameron said.

View Full Article in:

Financial Times (tiered subscription model) · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT